Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) traded up 8% on Wednesday . The company traded as high as $35.63 and last traded at $35.54. 114,090 shares were traded during trading, a decline of 82% from the average session volume of 650,629 shares. The stock had previously closed at $32.91.
Wall Street Analyst Weigh In
TRUP has been the topic of a number of recent research reports. Stifel Nicolaus lowered their target price on Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a research note on Thursday, February 20th. Piper Sandler lowered their price objective on Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $46.60.
Check Out Our Latest Analysis on Trupanion
Trupanion Stock Down 0.5 %
The company has a market cap of $1.51 billion, a price-to-earnings ratio of -154.13, a PEG ratio of 6.02 and a beta of 1.66. The business has a fifty day moving average of $37.85 and a two-hundred day moving average of $45.82. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39.
Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.06 by ($0.02). Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The business had revenue of $337.31 million during the quarter, compared to analysts' expectations of $335.41 million. As a group, equities analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.
Insider Buying and Selling at Trupanion
In related news, CFO Fawwad Qureshi sold 1,373 shares of the stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total value of $46,984.06. Following the completion of the transaction, the chief financial officer now directly owns 2,416 shares of the company's stock, valued at approximately $82,675.52. This represents a 36.24 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Emily Dreyer sold 14,025 shares of the firm's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $32.41, for a total value of $454,550.25. Following the completion of the transaction, the senior vice president now owns 27,645 shares in the company, valued at $895,974.45. The trade was a 33.66 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 29,792 shares of company stock valued at $989,442 over the last ninety days. Corporate insiders own 5.50% of the company's stock.
Institutional Investors Weigh In On Trupanion
A number of hedge funds have recently modified their holdings of TRUP. SBI Securities Co. Ltd. acquired a new position in Trupanion during the fourth quarter worth about $25,000. Jones Financial Companies Lllp lifted its stake in Trupanion by 71.7% in the 4th quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider's stock worth $27,000 after purchasing an additional 238 shares in the last quarter. Quarry LP acquired a new position in shares of Trupanion during the 4th quarter worth approximately $39,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of Trupanion in the third quarter valued at approximately $54,000. Finally, Aster Capital Management DIFC Ltd increased its holdings in shares of Trupanion by 988.5% in the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,132 shares of the financial services provider's stock valued at $55,000 after purchasing an additional 1,028 shares during the last quarter.
Trupanion Company Profile
(
Get Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Articles
Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.